Amir Butt, MD
Gastroenterology · Oshkosh, WINPI 1205931144
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,564 of the $4,244 with a category attached, or 60.4%. 9 manufacturers reported payments, led by Astrazeneca UK Limited at 38.0% of the total.
Across 29 payments — averaging $146.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$2K
- CSL Behring$1K
- Boston Scientific$281
- Olympus America Inc.$273
- E.r. Squibb & Sons, L.L.C.$228
- Conmed Corporation$132
- plus $341 from 3 others
What the payments were for
- Travel & lodging$2,56460%
- Food & beverage$1,68040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 10 | $1,614 |
| CSL Behring | 4 | $1,375 |
| Boston Scientific | 5 | $281 |
| Olympus America Inc. | 3 | $273 |
| E.r. Squibb & Sons, L.L.C. | 2 | $228 |
| Conmed Corporation | 2 | $132 |
| Intercept Pharmaceuticals, Inc. | 1 | $120 |
| Ferring Pharmaceuticals Inc. | 1 | $113 |
| Mallinckrodt Hospital Products Inc. | 1 | $108 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$1,471
- ZEPOSIA$228
- DISPOSABLE GRASPING FORCEPS$143
- EndoClot PHS$143
- OCALIVA$120
- CONMED GENERATORS$119
- CONMED BILIARY$119
- RESOLUTION CLIP$116
- HANAROSTENT LowAxTM Duodenum/Pylorus(NNN)$115
- REBYOTA$113
- TERLIVAZ$108
How this compares
$4,244 in reported general payments places this provider in the 85th percentile of 285 gastroenterology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 73 | $863 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $156 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Oshkosh
- Jeffrey AndreiniOshkosh$5K
- Daniel SteinMilwaukee$227K
- Amir PatelSheboygan$137K
- Poonam Beniwal-PatelMilwaukee$108K
- Lilani PereraMequon$95K
- Freddy CalderaMadison$72K
- Matthew PellerMilwaukee$63K
- Susan LepinskiMadison$61K
- Chetan MittalMilwaukee$53K
- Pedro Palacios ArguetaEau Claire$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.